金凯生科三位股东拟合计减持不超5.94%股份

Core Viewpoint - The shareholders of Jinkai Biotechnology (301509.SZ) plan to reduce their holdings in the company, indicating potential changes in ownership structure and investor sentiment [1] Shareholder Reduction Plans - Qilu Investment plans to reduce its holdings by up to 3.612 million shares, representing no more than 3% of the company's total share capital [1] - Qingsong Investment intends to reduce its holdings by up to 1.204 million shares, accounting for no more than 1% of the company's total share capital [1] - Blue Zone Fund plans to reduce its holdings by up to 2.3391 million shares, which is no more than 1.94% of the company's total share capital [1]